Chen Jicheng, Chang Rong
Department of Vasculocardiology, Shenzhen Longhua District Central Hospital, Guangdong Medical University, Shenzhen, China.
Front Pharmacol. 2022 Apr 20;13:888563. doi: 10.3389/fphar.2022.888563. eCollection 2022.
Transforming growth factor-beta (TGF-β) signaling is essential for the maintenance of the normal structure and function of the aorta. It includes SMAD-dependent canonical pathways and noncanonical signaling pathways. Accumulated genetic evidence has shown that TGF-β canonical signaling-related genes have key roles in aortic aneurysms (AAs) and aortic dissections and many gene mutations have been identified in patients, such as those for transforming growth factor-beta receptor one TGFBR1, TGFBR2, SMAD2, SMAD3, SMAD4, and SMAD6. Aortic specimens from patients with these mutations often show paradoxically enhanced TGF-β signaling. Some hypotheses have been proposed and new AA models in mice have been constructed to reveal new mechanisms, but the role of TGF-β signaling in AAs is controversial. In this review, we focus mainly on the role of canonical signaling-related core genes in diseases of the aorta, as well as recent advances in gene-mutation detection, animal models, and studies.
转化生长因子-β(TGF-β)信号传导对于维持主动脉的正常结构和功能至关重要。它包括依赖SMAD的经典途径和非经典信号通路。越来越多的遗传学证据表明,TGF-β经典信号相关基因在主动脉瘤(AA)和主动脉夹层中起关键作用,并且在患者中已鉴定出许多基因突变,例如转化生长因子-β受体1(TGFBR1)、TGFBR2、SMAD2、SMAD3、SMAD4和SMAD6的基因突变。具有这些突变的患者的主动脉标本通常显示出TGF-β信号传导异常增强。已经提出了一些假说,并构建了新的小鼠AA模型以揭示新机制,但TGF-β信号传导在AA中的作用仍存在争议。在本综述中,我们主要关注经典信号相关核心基因在主动脉疾病中的作用,以及基因突变检测、动物模型和研究的最新进展。